within Pharmacolibrary.Drugs.ATC.C;

model C09AA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.6,
    Cl             = 0.00022333333333333333,
    adminDuration  = 600,
    adminMass      = 2.5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.056,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.020000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C09AA08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cilazapril is an angiotensin-converting enzyme (ACE) inhibitor used primarily for the treatment of hypertension and congestive heart failure. It is usually administered orally and works by preventing the conversion of angiotensin I to angiotensin II, thereby reducing blood pressure. The drug is currently approved and in use in several countries, but not available in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Williams, PE, et al., &amp; Durnin, C (1989). The pharmacokinetics and bioavailability of cilazapril in normal man. <i>British journal of clinical pharmacology</i> 27 Suppl 2(Suppl 2) 181S–188S. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1989.tb03480.x&quot;>10.1111/j.1365-2125.1989.tb03480.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2527531/&quot;>https://pubmed.ncbi.nlm.nih.gov/2527531</a></p></li><li><p>Williams, PE, et al., &amp; Dewland, PM (1990). Pharmacokinetics of cilazapril during repeated oral dosing in healthy young volunteers. <i>European journal of drug metabolism and pharmacokinetics</i> 15(1) 63–67. DOI:<a href=&quot;https://doi.org/10.1007/BF03190129&quot;>10.1007/BF03190129</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2166672/&quot;>https://pubmed.ncbi.nlm.nih.gov/2166672</a></p></li><li><p>Massarella, J, et al., &amp; Brown, A (1989). The pharmacokinetics and dose proportionality of cilazapril. <i>British journal of clinical pharmacology</i> 27 Suppl 2(Suppl 2) 199S–204S. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1989.tb03482.x&quot;>10.1111/j.1365-2125.1989.tb03482.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2527533/&quot;>https://pubmed.ncbi.nlm.nih.gov/2527533</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C09AA08;
